Schedule 13G ownership disclosure
DERMATA THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 249845504
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIGGER CAPITAL FUND L P
Shares: 242,832.00 · Class: 4.90%
- Bigger Capital Fund GP, LLC
Shares: 242,832.00 · Class: 4.90%
- District 2 Capital Fund LP
Shares: 171,232.00 · Class: 3.46%
- District 2 Capital LP
Shares: 171,232.00 · Class: 3.46%
- District 2 GP LLC
Shares: 171,232.00 · Class: 3.46%
- District 2 Holdings LLC
Shares: 171,232.00 · Class: 3.46%
- Bigger Michael
Shares: 414,064.00 · Class: 8.36%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-26-002901
- Form type
- SCHEDULE 13G
- Filer
- Dermata Therapeutics, Inc.
- CIK
- CIK 1853816
- Filed
- Nov 02, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership